Published Jun 18, 2024

Labshares Announces Key Leadership Additions: Devon Lagasse Joins as VP of Growth and Emma Orfanos Is Promoted to Manager of Business Development

Press Releases

Newton, MA – June 2024

Labshares, a premier shared laboratory for emerging biotech and life science companies, is excited to announce two significant additions to its leadership team. Devon Lagasse has been appointed as Labshares’ new Vice President of Growth, and Emma Orfanos has been promoted to Manager of Business Development.

Devon Lagasse Joins Labshares as VP of Growth

Devon Lagasse brings a wealth of relevant experience to the position. With over 13 years at Eppendorf and MSD, Devon has a proven track record of developing deep relationships within the biotech and life science industry, expanding market presence, and driving growth. Her expertise will be invaluable as Labshares continues to expand its service offerings and footprint.

 

"We are thrilled to welcome Devon to our team," said Philip Borden, CEO of Labshares. "Her extensive industry knowledge and vision will be critical as we scale our operations and enhance our offerings to emerging biotech and life science companies. Devon will undoubtedly help us grow and reinforce Labshares’ position as the leading provider of shared lab services in Greater Boston."

Emma Orfanos Promoted to Manager of Business Development

Labshares is also proud to announce the promotion of Emma Orfanos to the role of Manager of Business Development. Emma has been with Labshares for two and a half years, during which she has demonstrated exceptional leadership and an ability to build and maintain relationships with Labshares members. She understands the needs of life science startups and her dedication to their success makes her a critical asset to the team.

"Emma has been instrumental in Labshares’ strong historic growth and she’ll continue to play a pivotal role in expanding our network and ensuring the success of our member companies. Her promotion is a testament to her hard work and outstanding contributions to Labshares."  said Phillip Borden, CEO of Labshares.

Related or similar articles

March 20, 2025

Labshares x BYTE51: A Game-Changing Partnership to Navigate Fundraising

Labshares News
May 17, 2024

Streamlining Procurement: Labshares Partners with Labviva for Enhanced Access and Efficiency

In the fast-paced world of biotech innovation, easy access to crucial resources is vital for research success. That's why Labshares is excited to share news of our partnership with Labviva, a top procurement platform reshaping how scientists obtain l
Labshares News
January 23, 2025

Labshares Enters 2025 with Significant Momentum

Press Releases